The intervention led to significant effects as shown by the significant treatment visit interactions observed in all the glycemia related biomarkers and the significant differences between groups in the rate of change of FBG and HbA1c (Table 2), which showed opposite directions during the intervention, decreasing in MO and increasing in PLC
We confirmed our RNA results at the single cell proteomic level and found significant downregulation of mTOR-pS6 and the metabolic proteins HK, GAPDH, G6PD, CD98, CS, ATP5A, FASN in rapamycin-treated products (Fig
What concerned reviewers was the discontinuation rate, the share of participants who stopped taking the drug due to side effects
CYANOCOBALAMIN injection, USP [DailyMed label]
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or Biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study
Oral or intravenous administration of levocarnitine can cause seizures, regardless of a prior history of epilepsy
